학술논문
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial
Document Type
Article
Author
Source
In: BMC Cancer . (BMC Cancer, December 2022, 22(1))
Subject
Language
English
ISSN
14712407